Focus Feature: Rallying to achieve vaccine equity
Getting COVID-19 vaccines to the neighborhoods where they were most needed was one of the greatest challenges health care providers experienced early in the pandemic. At Kaiser Permanente, physicians, researchers, diversity groups, and others rallied to meet this challenge.
R&E News and Features
Extra pounds put kids at higher risk for hypertension
Young people at the upper range of average weight had a 26% higher risk of developing hypertension than those closer to what is considered average weight.
Paxlovid associated with lower risk of hospital admission
New study confirms the benefit of Paxlovid as an early-stage treatment to prevent hospitalization for people with mild-to-moderate COVID-19, regardless of prior immunity or age.
Atrial fibrillation may increase risk for dementia
People who have been diagnosed with atrial fibrillation are known to have an increased risk of developing other heart problems. A new Kaiser Permanente study suggests they may also be at increased risk for dementia.
KPSC chosen for initiative aimed at improving patient outcomes
The Patient-Centered Outcomes Research Institute (PCORI) selected Kaiser Permanente Southern California as one of 42 health systems nationwide to carry out a pioneering initiative aimed at improving patient outcomes.
2022 SCPMG Physician Researcher of the Year named
Dr. William J. Towner, physician director of the Kaiser Permanente Southern California Clinical Trials Program, was named the 2022 Southern California Permanente Medical Group Physician Researcher of the Year.
In the News
Socioeconomic, racial/ethnic, and health care system disparities in melanoma-specific mortality
Physician's WeeklyMarch 22, 2023Paxlovid 80% effective against severe COVID when taken in first 5 days
Center for Infectious Disease Research & PolicyMarch 16, 2023Restricting antibiotics for livestock could limit spread of antibiotic-resistant infections in people
Science DailyFebruary 22, 2023ASCVD risk assessment practices miss opportunity to identify eligible young adults
HealioFebruary 13, 2023Dampened response to COVID-19 vaccines in Rituxan-treated patients with MS may improve with extended dosing intervals
Managed Healthcare ExecutiveJanuary 24, 2023
Five questions...
for Dr. Wu
Meet Dr. Bechien Wu, a gastroenterologist at the Kaiser Permanente Los Angeles Medical Center, who was recently appointed to be the physician director of the Department of Research & Evaluation’s new Clinician Research division.